Editas Medicine
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $3,578 | $4,658 | $30,604 | $61 |
Gross Profit | 3,578 | 4,658 | 29,223 | -1,538 |
EBITDA | -49,381 | -71,955 | -44,014 | -60,542 |
EBIT | -51,215 | -73,872 | -45,395 | -62,141 |
Net Income | -53,235 | -76,088 | -45,395 | -62,141 |
Net Change In Cash | 3,578 | 4,658 | 30,604 | 61 |
Free Cash Flow | -50,212 | -47,913 | -51,302 | -55,509 |
Cash | 138,542 | 138,692 | 131,541 | 95,832 |
Basic Shares | 84,412 | 83,055 | 82,613 | 82,485 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $32,314 | $78,123 | $19,712 | $25,544 |
Gross Profit | 26,505 | 72,059 | 19,712 | 25,544 |
EBITDA | -233,111 | -163,117 | -219,613 | -188,093 |
EBIT | -238,920 | -169,181 | -225,950 | -193,146 |
Net Income | -237,093 | -153,219 | -204,352 | -185,107 |
Net Change In Cash | 32,314 | 78,123 | 19,712 | 25,544 |
Cost of Revenue | -61,997 | 63,837 | ||
Free Cash Flow | -219,110 | -136,897 | -181,467 | -171,780 |
Cash | 131,541 | 123,652 | 141,522 | 203,519 |
Basic Shares | 82,338 | 75,965 | 68,664 | 67,619 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.63 |
2025-03-31 | -$0.92 |
2024-12-31 | -$0.55 |
